• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number GSX0025A
Device Problem Mechanical Problem (1384)
Patient Problem No Information (3190)
Event Date 07/14/2020
Event Type  Injury  
Manufacturer Narrative
Citation: sahil khera, richard ro, barry love, parasuram krishnamoorthy, gila perk, gilbert h.L.Tang, samin sharma, annapoorna kini & stamatios lerakis (2020) extreme right atrial disc expansion of septal occluder post iatrogenic atrial septal defect closure, structural heart, doi: 10.1080/24748706.2020.1790704.The gore® cardioform septal occluder instructions for use note that the device is indicated for the percutaneous, transcatheter closure of ostium secundum atrial septal defects (asds).The authors note the device was used to close an iatrogenic asd, which is considered off-label use for this device.Additionally, the gore® cardioform septal occluder instructions for use note intervention for device failure or ineffectiveness as a potential device or procedure-related adverse event.
 
Event Description
This information was received through literature article "extreme right atrial disc expansion of septal occluder post iatrogenic atrial septal defect closure" posted online 14 july 2020 in structural heart.The article reports a (b)(6) male underwent successful mitracip transcatheter mitral valve repair.The residual atrial septal defect (asd) was measured at 12mm x 12mm by doppler and the decision was made to close the asd due to the large left to right shunt.Implantation of a 25mm gore® cardioform septal occluer was uneventful, with transesophageal echocardiography (tee) demonstrating good device apposition and normal device appearance.Tee performed the following morning demonstrated a circular echodensity at the right atrial side of the interatrial septum.With further evaluation via fluoroscopy, extreme expansion of the right atrial disc with displacement of the locking pin was seen.The device was removed with a gooseneck snare and bioptome.An alternative nitinol mesh-based occluder was implanted with unremarkable appearance on follow-up imaging.
 
Event Description
2020-01109-1.
 
Manufacturer Narrative
This report was inadvertently duplicated and will be retracted.The original manufacturer report number is 2017233-2019-00637.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE CARDIOFORM SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10391279
MDR Text Key202424781
Report Number2017233-2020-01109
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Type of Report Initial,Followup
Report Date 08/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberGSX0025A
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/21/2020
Initial Date FDA Received08/11/2020
Supplement Dates Manufacturer Received07/21/2020
Supplement Dates FDA Received08/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age72 YR
-
-